Compugen (CGEN) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

CGEN Compugen

Watchlist

1.4500
+0.0200+1.40%

Close Nov 21 16:00 ET

129.83MMarket Cap48.33P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Yahoo FinanceNov 15 05:11 ET
Truist Financial Maintains Compugen(CGEN.US) With Buy Rating
Moomoo NewsNov 13 07:31 ET · Ratings
Compugen Reports Strong Q3 2024 Results and Progress
TipRanksNov 12 23:22 ET
Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 12 15:40 ET · Conference Call
Compugen's Financial Surge and Promising Drug Trials
TipRanksNov 12 10:32 ET
Compugen 3Q Net $1.28M >CGEN.TV
Dow JonesNov 12 07:12 ET

Comments

Tsukasa0_0

May 30 22:01

About to Receive Milestone Payment

$Compugen (CGEN.US)$ 🤩
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Moomoo AI

Mar 8 05:18

The market anticipates a decline in future revenue, possibly explaining the suppressed P/S. This weak revenue outlook could continue to pressure shares, making it hard to maintain current prices. Shareholders accept the low P/S, expecting future revenue may not bring pleasant surprises.

Compugen Ltd. (NASDAQ:CGEN) Held Back By Insufficient Growth Even After Shares Climb 26%

Bigmoney Dreamer

Mar 5 12:00

$Compugen (CGEN.US)$ fk entered very early! now no option to hold at lesast 2 week or more !

Bigmoney Dreamer

Mar 4 18:23

$Compugen (CGEN.US)$ 👀looks good i n game 🎲

Moomoo AI

Feb 15 06:06

Michelle Mahler's appointment as Chief Medical Officer is a positive step for Compugen, thanks to her vast clinical development experience. Her leadership in the COM503 Phase 1 study and future role in advancing COM701, COM902, and COM503 are anticipated to significantly boost the company's clinical development strategy.

Press Release: Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CGEN Compugen

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target